Pituitary-adrenal responses to cholinergic stimulation and acute mild stress are differentially elevated in male and female M2 muscarinic receptor knockout mice

Journal of Neuroendocrinology

Volumn 17, Issue 12, 2005, Pages 817-826

  Rhodes, Michael E ^a,b   Billings, T E ^a   Czambel, R K ^a   Rubin, R T ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b SAINT VINCENT COLLEGE   (United States)

Author keywords

Cholinergic; Diergism; Knockout; Muscarinic; Pituitary adrenal

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; MUSCARINIC M2 RECEPTOR; OXOTREMORINE; PHYSOSTIGMINE; SCOPOLAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; FEMALE; GENOTYPE; HORMONAL REGULATION; HORMONE RESPONSE; HORMONE SENSITIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SEX DIFFERENCE; STRESS; WILD TYPE;

ACUTE DISEASE; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CHOLINESTERASE INHIBITORS; CORTICOSTERONE; FEMALE; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUSCARINIC AGONISTS; OXOTREMORINE; PHYSOSTIGMINE; PITUITARY GLAND; RECEPTOR, MUSCARINIC M2; SEX CHARACTERISTICS; SODIUM CHLORIDE; STRESS;

EID: 28044446341     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2005.01376.x     Document Type: Article

References (53)

1. Wess J. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. Annu Rev Pharmacol Toxicol 2004; 44: 423-450.
2. Levey AI. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 1993; 52: 441-448.
3. Caulfield MP. Muscarinic receptors - characterization, coupling and function. Pharmacol Ther 1993; 58: 319-379.
4. Brann MR, Ellis J, Jorgensen H, Hill-Eubanks D, Jones SV. Muscarinic acetylcholine receptor subtypes: localization and structure/function. Prog Brain Res 1993; 98: 121-127.
5. Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 1991; 11: 3218-3226.
6. Basile AS, Fedorova I, Zapata A, Liu X, Shippenberg T, Duttaroy A, Yamada M, Wess J. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc Natl Acad Sci USA 2002; 99: 11452-11457.
7. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 1996; 10: 69-99.
8. Tzavara ET, Bymaster FP, Felder CC, Wade M, Gomeza J, Wess J, McKinzie DL, Nomikos GG. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice. Mol Psychiatry 2003; 8: 673-679.
9. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, Idzerda RL, Nathanson NM. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 1997; 94: 13311-13316.
10. Gomeza J, Shannon H, Kostenis E, Felder C, Zhang L, Brodkin J, Grinberg A, Sheng H, Wess J. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 1999; 96: 1692-1697.
11. Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, Wess J. Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 2001; 98: 14096-14101.
12. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 2001; 410: 207-212.
13. Gomeza J, Zhang L, Kostenis E, Felder CC, Bymaster FP, Brodkin J, Shannon H, Xia B, Duttaroy A, Deng CX, Wess J. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice. Life Sci 2001; 68: 2457-2466.
14. Zhang W, Basile AS, Gomeza J, Volpicelli LA, Levey AI, Wess J. Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J Neurosci 2002; 22: 1709-1717.
15. Rubin RT, Sekula LK, O'Toole S, Rhodes ME, Czambel RK. Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men. Neuropsychopharmacology 1999; 20: 434-446.
16. Rubin RT, O'Toole SM, Rhodes ME, Sekula LK, Czambel RK. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration. sex differences between major depressives and matched control subjects. Psychiatry Res 1999; 89: 1-20.
17. Rubin RT, Rhodes ME, O'Toole S, Czambel RK. Sexual diergism of hypothalamo-pituitary-adrenal cortical responses to low-dose physotigmine in elderly vs. young women and men. Neuropsychopharmacology 2002; 26: 672-681.
18. Rhodes ME, Rubin RT. Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review. Brain Res Brain Res Rev 1999; 30: 135-152.
19. Rhodes ME, O'Toole SM, Wright SL, Czambel RK, Rubin RT. Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism. Brain Res Bull 2001; 54: 101-113.
20. Rhodes ME, O'Toole SM, Czambel RK, Rubin RT. Male-female differences in rat hypothalamic-pituitary-adrenal axis responses to nicotine stimulation. Brain Res Bull 2001; 54: 681-688.
21. Rhodes ME, Balestreire EM, Kenneth Czambel R, Rubin RT. Estrous cycle influences on sexual diergism of HPA axis responses to cholinergic stimulation in rats. Brain Res Bull 2002; 59: 217-225.
22. Rhodes ME, Czambel RK, Wess J, Rubin RT. Sexual diergism of HPA axis responses to cholinergic stimulation in M2 receptor knockout and wild-type mice. Soc Neurosci Abstract 2002; 238: 10.
23. Hemrick-Luecke SK, Bymaster FP, Evans DC, Wess J, Felder CC. Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice. J Pharmacol Exp Ther 2002; 303: 99-103.
24. Baghdoyan HA, Lydic R, Fleegal MA. M2 muscarinic autoreceptors modulate acetylcholine release in the medial pontine reticular formation. J Pharmacol Exp Ther 1998; 286: 1446-1452.
25. Gomeza J, Zhang L, Kostenis E, Felder C, Bymaster F, Brodkin J, Shannon H, Xia B, Deng C, Wess J. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M(4) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 1999; 96: 10483-10488.
26. Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE, Nathanson NM, McKinzie DL, Felder CC. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci 2003; 17: 1403-1410.
27. Sanchez C, Lembol HL. The involvement of muscarinic receptor subtypes in the mediation of hypothermia, tremor, and salivation in male mice. Pharmacol Toxicol 1994; 74: 35-39.
28. Song X, Tian H, Bressler J, Pruett S, Pope C. Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats. Toxicol Sci 2002; 69: 157-164.
29. Wang N, Orr-Urtreger A, Chapman J, Rabinowitz R, Korczyn AD. Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor. J Neurol Sci 2004; 222: 87-91.
30. Jung M, Perio A, Worms P, Soubrie P. Pharmacological characterization of the physostigmine stimulus in rats. Psychopharmacology (Berl) 1988; 95: 553-555.
31. Sheardown MJ, Shannon HE, Swedberg MD, Suzdak PD, Bymaster FP, Olesen PH, Mitch CH, Ward JS, Sauerberg P. M1 receptor agonist activity is not a requirement for muscarinic antinociception. J Pharmacol Exp Ther 1997; 281: 868-875.
32. Espinola EB, Oliveira MG, Carlini EA. Differences in central and peripheral responses to oxotremorine in young and aged rats. Pharmacol Biochem Behav 1999; 62: 419-423.
33. Duttaroy A, Gomeza J, Gan JW, Siddiqui N, Basile AS, Harman WD, Smith PL, Felder CC, Levey AI, Wess J. Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. Mol Pharmacol 2002; 62: 1084-1093.
34. Saiyed M, Riker WK. Cholinergic and anticholinergic drug effects on survival during hypoxia: significant gender differences. J Pharmacol Exp Ther 1993; 264: 1146-1153.
35. Raff H, Findling JW. A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome. Clin Chem 1989; 35: 596-600.
36. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet 2000; 24: 403-409.
37. Laurent V, Kimble A, Peng B, Zhu P, Pintar JE, Steiner DF, Lindberg I. Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion. Proc Natl Acad Sci USA 2002; 99: 3087-3092.
38. Starke K, Gothert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 1989; 69: 864-989.
39. Le Mevel JC, Abitbol S, Beraud G, Maniey J. Temporal changes in plasma adrenocorticotropin concentration after repeated neurotropic stress in male and female rats. Endocrinology 1979; 105: 812-817.
40. Rimanoczy A, Slamberova R, Riley MA, Vathy I. Adrenocorticotropin stress response but not glucocorticoid-negative feedback is altered by prenatal morphine exposure in adult male rats. Neuroendocrinology 2003; 78: 312-320.
41. Garcia A, Marti O, Valles A, Dal-Zotto S, Armario A. Recovery of the hypothalamic-pituitary-adrenal response to stress. Effect of stress intensity, stress duration and previous stress exposure. Neuroendocrinology 2000; 72: 114-125.
42. Janossy A, Li JY, Saez JM. Characterisation of the muscarinic receptor subtype M3 in the bovine zona fasciculata-reticularis cells by receptor binding, mRNA and functional studies. J Endocrinol 1999; 163: 329-336.
43. Clyne CD, Walker SW, Nicol MR, Williams BC. The M3 muscarinic receptor mediates acetylcholine-induced cortisol secretion from bovine adrenocortical zona fasciculata/reticularis cells. Biochem Pharmacol 1994; 47: 1145-1150.
44. Young EA. Sex differences in response to exogenous corticosterone: a rat model of hypercortisolemia. Mol Psychiatry 1996; 1: 313-319.
45. Moidel MA, Fulton BA, Czambel RK, Rubin RT, Rhodes ME. Hypothalamic-pituitary-adrenal axis responses to cholinergic drugs and hormones in an in vitro perfusion system. Soc Neurosci Abstract 2004; 315: 92.
46. Avissar S, Egozi Y, Sokolovsky M. Biochemical characterization and sex dimorphism of muscarinic receptors in rat adenohypophysis. Neuroendocrinology 1991; 32: 303-309.
47. Porter AC, Bymaster FP, DeLapp NW, Yamada M, Wess J, Hamilton SE, Nathanson NM, Felder CC. M1 muscarinic receptor signaling in mouse hippocampus and cortex. Brain Res 2002; 944: 82-89.
48. Tolliver JM, Taylor RL, Burt DR. Muscarinic receptors in the posterior pituitary gland. Neuroendocrinology 1981; 32: 33-37.
49. Mukherjee A, Snyder G, McCann SM. Characterization of muscarinic cholinergic receptors on intact rat anterior pituitary cells. Life Sci 1980; 27: 475-482.
50. Avissar S, Egozi Y, Sokolovsky M. Aging process decreases the density of muscarinic receptors in rat adenohypophysis. FEBS Lett 1981; 133: 275-278.
51. Michels KM, Meeker RB, Hayward JN. Muscarinic cholinergic control of vasopressin secretion from the acute hypothalamoneurohypophysial explant. Neuroendocrinology 1991; 54: 219-226.
52. Pinter I, Moszkovszkin G, Nemethy Z, Makara GB. Muscarinic M1 and M3 receptors are present and increase intracellular calcium in adult rat anterior pituitary gland. Brain Res Bull 1999; 48: 449-456.
53. Wess J, Duttaroy A, Gomeza J, Zhang W, Yamada M, Felder CC, Bernardini N, Reeh PW. Muscarinic receptor subtypes mediating central and peripheral antinociception studied with muscarinic receptor knockout mice: a review. Life Sci 2003; 72: 2047-2054.